Calendar Sagimet Biosciences Inc.

Equities

SGMT

US7867001049

End-of-day quote Nasdaq 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
4.62 USD +5.48% Intraday chart for Sagimet Biosciences Inc. +4.05% -14.76%

Chart calendar Sagimet Biosciences Inc.

1bcabb80bc1d088d3.EOLCJ_0Xzs5Ok6OdNopF9yPJsSpXq-Gp8U9G0ugdZpo.WNfvcaxApLgm2c6oBb48x0KvhF9i7pv7ngsUk7dqE9slgbZqk1mmpiL-5g~4e3c46525648eac14e6c0279144231b8

Upcoming events on Sagimet Biosciences Inc.

2024-06-05 01:00 pm Annual General Meeting
2024-06-06 06:15 am EASL International Liver Congress
2024-08-18 Q2 2024 Earnings Release (Projected)
2024-11-10 Q3 2024 Earnings Release (Projected)
2025-03-30 Q4 2024 Earnings Release (Projected)
2025-05-13 Q1 2025 Earnings Release (Projected)

Past events on Sagimet Biosciences Inc.

2024-05-15 08:00 am Q1 2024 Earnings Release
2024-05-03 12:30 pm Investor and Analyst Day
2024-03-25 06:15 am Q4 2023 Earnings Release
2024-03-13 08:00 am Leerink Partners Global Biopharma Conference
2024-03-05 02:10 pm TD Cowen Health Care Conference
2024-01-22 08:00 am FASCINATE-2 Phase 2b Clinical Trial Results Call
2023-12-06 12:00 pm Goldman Sachs Catalyst Clinic Conference
2023-11-29 03:30 pm Piper Sandler Healthcare Conference
2023-11-28 12:30 pm Obesity and NASH Drug Development Summit
2023-11-13 08:00 am Q3 2023 Earnings Release
2023-11-11 01:00 pm American Association for the Study of Liver Diseases Conference
2023-11-09 American Association for the Study of Liver Diseases Conference
2023-10-24 03:00 pm H.C. Wainwright NASH Investor Conference
2023-08-21 04:02 pm Q2 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


2,00
2,00
0%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-30,7
-33,1
7.04%

-59,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-27,9
-31,1
10.32%

-61,1

Net income
Million USD
Released
Forecast
Spread
-30,5


-27,9
-31,1
10.32%

-61,1

EPS
USD
Released
Forecast
Spread
-165


-2,66
-3,19
16.61%

-2,06

Announcement Date24/03/2325/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
2,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-7,06
-8,70
18.89%
-7,45
-10,2
26.65%
-9,47
-11,8
19.69%
-8,77
-10,7
17.87%

-11,0


-14,4


-21,8


-27,2


-29,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,79
-7,40
8.31%
-6,35
-9,35
32.02%
-8,15
-11,4
28.33%
-6,63
-10,4
36.01%

-11,5


-16,5


-26,4


-27,2


-29,4

Net income
Million USD
Released
Forecast
Spread
-6,79
-7,50
9.53%
-6,35
-9,40
32.38%
-8,15
-11,4
28.64%
-6,63
-10,4
36.38%

-11,5


-16,5


-26,4


-27,2


-29,4

EPS
USD
Released
Forecast
Spread
-35,8
-0,44
-8036.36%
-0,35
-1,02
65.52%

-0,53

-0,23
-0,41
43.9%

-0,39


-0,55


-0,88


-0,93


-1,00

Announcement Date21/08/2313/11/2325/03/2415/05/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SGMT Stock
  4. Calendar Sagimet Biosciences Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW